Gelatin/Hyaluronic Acid Scaffold Coupled to CpG and MAGE-A5 as a Treatment against Murine Melanoma

The half-time of cells and molecules used in immunotherapy is limited. Scaffolds-based immunotherapy against cancer may increase the half-life of the molecules and also support the migration and activation of leukocytes in situ. For this purpose, the use of gelatin (Ge)/hyaluronic acid (HA) scaffold...

Descripción completa

Detalles Bibliográficos
Autores principales: Piñón-Zárate, Gabriela, Hernández-Téllez, Beatriz, Jarquín-Yáñez, Katia, Herrera-Enríquez, Miguel Ángel, Fuerte-Pérez, América Eréndira, Valencia-Escamilla, Esther Alejandra, Castell-Rodríguez, Andrés Eliú
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9657831/
https://www.ncbi.nlm.nih.gov/pubmed/36365602
http://dx.doi.org/10.3390/polym14214608

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9657831/
https://www.ncbi.nlm.nih.gov/pubmed/36365602
http://dx.doi.org/10.3390/polym14214608

Ejemplares similares